Troy Bremer

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Neil L. Spector, Wenle Xia, Howard A. Burris et al. · Journal of Clinical Oncology · 2005 · 365 citations · Full text

Medicine, Oncology, Pharmacology +17

Is blood glucose predictable from previous values? A solicitation for data.

Troy Bremer, David Gough · Diabetes · 1999 · 147 citations

Medicine, Endocrinology, Diabetology +12

A Biological Signature for Breast Ductal Carcinoma <i>In Situ</i> to Predict Radiotherapy Benefit and Assess Recurrence Risk

Troy Bremer, Pat W. Whitworth, Rakesh Patel et al. · Clinical Cancer Research · 2018 · 126 citations

Medicine, Oncology, Radiation Oncology +17

Validation of a Ductal Carcinoma <i>In Situ</i> Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy

Sheila Weinmann, Michael C. Leo, Melanie Francisco et al. · Clinical Cancer Research · 2020 · 69 citations

Medicine, Biostatistics, Surgery +17

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

Steven P. Linke, Troy Bremer, Christopher D Herold et al. · Clinical Cancer Research · 2006 · 66 citations

Medicine, Biostatistics, Oncology +17